Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Divya Vohora

Showing results (131-140 of 141) with videos related to

Pageof 15
Sort By:
International Journal of Pharmaceutics|April 27, 2016
Revisiting bone targeting potential of novel hydroxyapatite based surface modified PLGA nanoparticles of risedronate: Pharmacokinetic and biochemical assessmentPurnima Rawat, Iqbal Ahmad, Shindu C Thomas, et al.
Journal of Drug Targeting|May 8, 2025
Investigating the osteogenic potential of bone-targeted daidzein loaded hydroxyapatite nanoparticles for postmenopausal osteoporosis: pharmacodynamic, biochemical, and genotoxicity evaluationsNamrata Gautam, Prashant Sharma, Antra Chaudhary, et al.
Phytochemical Analysis : PCA|October 29, 2009
Quantitative analysis of safranal in saffron extract and nanoparticle formulation by a validated high-performance thin-layer chromatographic methodShadab Ahmad Pathan, Sanjar Alam, Gaurav K Jain, et al.
Pharmaceutics|September 28, 2023
Enhancing Osteoporosis Treatment through Targeted Nanoparticle Delivery of Risedronate: In Vivo Evaluation and Bioavailability EnhancementZoya Saifi, Sadat Shafi, Tanya Ralli, et al.
Drug Delivery and Translational Research|November 23, 2023
Raloxifene encapsulated spanlastic nanogel for the prevention of bone fracture risk via transdermal administration: Pharmacokinetic and efficacy study in animal modelMohd Danish Ansari, Sadat Shafi, Jayamanti Pandit, et al.
The Journal of Pharmacy and Pharmacology|October 3, 2024
Osteogenic effect of alogliptin in chemical-induced bone loss: a tri-modal in silico, in vitro, and in vivo analysisFaraha Ahmed, Syed Sufian Ahmad, Mohammad Mumtaz Alam, et al.
International Journal of Molecular Sciences|April 26, 2019
Systems Approach to Identify Common Genes and Pathways Associated with Response to Selective Serotonin Reuptake Inhibitors and Major Depression RiskAnkit Srivastava, Priyanka Singh, Hitesh Gupta, et al.
Current Pharmaceutical Design|July 1, 2026
Nanostructured Lipid Carriers in Drug Targeting: Characterization, Patents, and Recent InnovationsRabnoor Alam, Nida Nehal, Devika Unnithan, et al.
Biomedical Chromatography : BMC|August 25, 2010
Stability-indicating ultra-performance liquid chromatography method for the estimation of thymoquinone and its application in biopharmaceutical studiesShadab A Pathan, Gaurav K Jain, Syed M A Zaidi, et al.
Frontiers in Pharmacology|May 12, 2025
<i>In vitro</i> and <i>in-vivo</i> exploration of physostigmine analogues to understand the mechanistic crosstalk between Klotho and targets for epilepsyMansi Dahalia, Haya Majid, Mohd Junaid Khan, et al.
Pageof 15

Showing results (131-140 of 141) with videos related to

Sort By:
Pageof 15
International Journal of Pharmaceutics|April 27, 2016
Revisiting bone targeting potential of novel hydroxyapatite based surface modified PLGA nanoparticles of risedronate: Pharmacokinetic and biochemical assessmentPurnima Rawat, Iqbal Ahmad, Shindu C Thomas, et al.
Journal of Drug Targeting|May 8, 2025
Investigating the osteogenic potential of bone-targeted daidzein loaded hydroxyapatite nanoparticles for postmenopausal osteoporosis: pharmacodynamic, biochemical, and genotoxicity evaluationsNamrata Gautam, Prashant Sharma, Antra Chaudhary, et al.
Phytochemical Analysis : PCA|October 29, 2009
Quantitative analysis of safranal in saffron extract and nanoparticle formulation by a validated high-performance thin-layer chromatographic methodShadab Ahmad Pathan, Sanjar Alam, Gaurav K Jain, et al.
Pharmaceutics|September 28, 2023
Enhancing Osteoporosis Treatment through Targeted Nanoparticle Delivery of Risedronate: In Vivo Evaluation and Bioavailability EnhancementZoya Saifi, Sadat Shafi, Tanya Ralli, et al.
Drug Delivery and Translational Research|November 23, 2023
Raloxifene encapsulated spanlastic nanogel for the prevention of bone fracture risk via transdermal administration: Pharmacokinetic and efficacy study in animal modelMohd Danish Ansari, Sadat Shafi, Jayamanti Pandit, et al.
The Journal of Pharmacy and Pharmacology|October 3, 2024
Osteogenic effect of alogliptin in chemical-induced bone loss: a tri-modal in silico, in vitro, and in vivo analysisFaraha Ahmed, Syed Sufian Ahmad, Mohammad Mumtaz Alam, et al.
International Journal of Molecular Sciences|April 26, 2019
Systems Approach to Identify Common Genes and Pathways Associated with Response to Selective Serotonin Reuptake Inhibitors and Major Depression RiskAnkit Srivastava, Priyanka Singh, Hitesh Gupta, et al.
Current Pharmaceutical Design|July 1, 2026
Nanostructured Lipid Carriers in Drug Targeting: Characterization, Patents, and Recent InnovationsRabnoor Alam, Nida Nehal, Devika Unnithan, et al.
Biomedical Chromatography : BMC|August 25, 2010
Stability-indicating ultra-performance liquid chromatography method for the estimation of thymoquinone and its application in biopharmaceutical studiesShadab A Pathan, Gaurav K Jain, Syed M A Zaidi, et al.
Frontiers in Pharmacology|May 12, 2025
<i>In vitro</i> and <i>in-vivo</i> exploration of physostigmine analogues to understand the mechanistic crosstalk between Klotho and targets for epilepsyMansi Dahalia, Haya Majid, Mohd Junaid Khan, et al.
Pageof 15